Healthcare technology leader urges Congress to pass bipartisan legislation securing senior access to pharmacist-delivered clinical services

XiFin, Inc., a leader in AI-driven revenue cycle management solutions and a business partner to more than half of pharmacies across the United States, today expressed strong support for H.R. 3164, the Main Street Pharmacy Access Act, which was advanced by the full House Ways and Means Committee after mark-up. The legislation has earned broad, bipartisan support, with more than 100 Congressional co-sponsors and the support of major healthcare organizations. XiFin joins other advocates in urging Congress to advance the legislation.

The Main Street Pharmacy Access Act ensures that America’s seniors have the same access as other healthcare consumers to essential pharmacist services, including testing and treatment for common respiratory illnesses, such as flu, strep throat, and RSV.

Medicare beneficiaries currently are not eligible for reimbursement for these and other pharmacist-provided clinical services already authorized by state laws. By addressing this gap, the Main Street Pharmacy Access Act would improve access to timely care for seniors and support the financial sustainability of community pharmacies.

“XiFin is encouraged that the House Ways and Means Committee yesterday moved to advance the Main Street Pharmacy Access Act. This legislation is particularly critical for seniors in rural and underserved areas, where pharmacies fill an important care gap. By reimbursing for these services, the legislation secures access for seniors and provides financial support for pharmacies so that they can continue to operate and serve their communities,” said David Pope, PharmD, Chief Pharmacy Officer at XiFin.

XiFin’s support for H.R. 3164 builds on the company’s broader commitment to breaking down barriers to care and advancing interoperability, with the ultimate goals of enhancing care and improving the patient experience. The company recently joined the Future of Pharmacy Care Coalition to add its voice to others working to improve delivery of clinical care.

About XiFin

XiFin is a healthcare information technology company that empowers organizations to navigate an evolving and increasingly complex healthcare landscape. The XiFin Empower AI RCM ecosystem and trusted data employ active intelligence and automation to reduce manual touches, coordinate workflows, accelerate customer innovation, and improve financial outcomes. Our comprehensive set of solutions — spanning revenue cycle management, clinical workflow enablement, laboratory information systems, and patient engagement — deliver The Power to Do Good® so that healthcare organizations can do more good for more patients. Visit www.XiFin.com or follow XiFin on LinkedIn to learn more, or subscribe to the XiFin blog to learn more.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260522757990/en/

“XiFin is encouraged that the House Ways and Means Committee yesterday moved to advance the Main Street Pharmacy Access Act," said David Pope, PharmD, Chief Pharmacy Officer at XiFin.